by Benzinga Insights | Jan 20, 2026 | General
Looking into the current session, GSK Inc. (NYSE:GSK) shares are trading at $47.74, after a 0.99% drop. Over the past month, the stock decreased by 2.26%, but over the past year, it actually increased by 42.82%. With questionable short-term performance like this, and...
by Benzinga Insights | Jan 20, 2026 | General
Vanguard Growth ETF (NYSE:VUG) has outperformed the market over the past 15 years by 2.7% on an annualized basis producing an average annual return of 14.34%. Currently, Vanguard Growth ETF has a market capitalization of $196.97 billion. Buying $100 In VUG: If an...
by Parshwa Turakhiya | Jan 20, 2026 | General
Bitcoins (CRYPTO: BTC) longtime skeptic Peter Schiff on Tuesday warned that Bitcoin holders who bought for the same reasons he bought gold will lose money, even when their economic forecasts prove correct. Schiff’s Warning: Right Thesis, Wrong Asset Schiff posted on X...
by Vandana Singh | Jan 20, 2026 | General
Valneva SE (NASDAQ:VALN) on Monday said it has decided to voluntarily withdraw the biologics license application (BLA) and Investigational New Drug (IND) application for its chikungunya vaccine, Ixchiq, in the U.S. In August 2025, the U.S. Food and Drug Administration...
by Piero Cingari | Jan 20, 2026 | General
One year into President Donald Trump’s return to the Oval Office, global equity performance tells a story few U.S. investors would have expected: two country markets have outperformed the S&P 500 by almost 90 percentage points over the past year. Despite...
Recent Comments